» Articles » PMID: 29898740

Prognostic Value of Myocardial Strain and Late Gadolinium Enhancement on Cardiovascular Magnetic Resonance Imaging in Patients with Idiopathic Dilated Cardiomyopathy with Moderate to Severely Reduced Ejection Fraction

Overview
Publisher Elsevier
Date 2018 Jun 15
PMID 29898740
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It has been reported that left ventricular (LV) myocardial strain and late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging have prognostic value in patients with heart failure (HF). However, previous studies included patients with various systolic functions. This study aimed to investigate the prognostic value of LV myocardial strain and LGE on CMR imaging in patients with idiopathic dilated cardiomyopathy (DCM) with reduced ejection fraction (EF < 40%).

Methods: From a prospectively followed cohort who underwent CMR between November 2008 and December 2015, subjects with LV EF < 40% and a diagnosis of idiopathic DCM were eligible for this study. The CMR images were analyzed for LV and right ventricular (RV) function, presence and extent of LGE, and LV myocardial strain. The primary outcome was a composite of all-cause death and heart transplantation. The secondary outcome was hospitalization for HF.

Results: A total of 172 patients were included, in whom mean LV EF was 23.7 ± 7.9% (EF 30-40% n = 47; EF < 30% n = 125). During a median follow-up of 47 months, the primary outcome occurred in 43 patients (16 heart transplantations, 29 all-cause deaths), and there were 41 hospitalizations for HF. Univariate Cox proportional hazard regression analysis showed that mean arterial pressure, serum sodium concentration, log of plasma NT-proBNP level, and presence of LGE (HR 2.277, 95% CI: 1.221-4.246) were significantly associated with the primary outcome. However, LV strain had no significant association (HR 1.048, 95% CI: 0.945-1.163). Multivariable analysis showed that presence of LGE (HR 4.73, 95% CI: 1.11-20.12) and serum sodium (HR 0.823, 95% CI: 0.762-0.887) were independently associated with the primary outcome.

Conclusions: LGE in CMR imaging was a good predictor of adverse outcomes for patients with idiopathic DCM and reduced EF. Identification of LGE could thus improve risk stratification in high-risk patients. LV strain had no significant prognostic value in patients with moderate to severe systolic dysfunction.

Citing Articles

Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: A Systematic Review and Meta-Analysis.

Eichhorn C, Koeckerling D, Reddy R, Ardissino M, Rogowski M, Coles B JAMA. 2024; .

PMID: 39298146 PMC: 11413760. DOI: 10.1001/jama.2024.13946.


Potential prognostic impact of left-ventricular global longitudinal strain in analysis of whole-heart myocardial mechanics in nonischemic dilated cardiomyopathy.

Melinyte-Ankudavice K, Marcinkeviciene K, Galnaitiene G, Bucius P, Lapinskas T, Ereminiene E Int J Cardiovasc Imaging. 2024; 40(9):1941-1949.

PMID: 38958878 PMC: 11473532. DOI: 10.1007/s10554-024-03184-x.


Complete spatiotemporal quantification of cardiac motion in mice through enhanced acquisition and super-resolution reconstruction.

Mukherjee T, Keshavarzian M, Fugate E, Naeini V, Darwish A, Ohayon J bioRxiv. 2024; .

PMID: 38895261 PMC: 11185553. DOI: 10.1101/2024.05.31.596322.


Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy.

Perone F, Dentamaro I, La Mura L, Alifragki A, Marketou M, Cavarretta E J Clin Med. 2024; 13(4).

PMID: 38398330 PMC: 10889760. DOI: 10.3390/jcm13041017.


Fractal analysis: another tool for the toolbox for dilated cardiomyopathy prognostication?.

Chan F, Captur G J Cardiovasc Magn Reson. 2024; 26(1):101004.

PMID: 38309580 PMC: 10944259. DOI: 10.1016/j.jocmr.2024.101004.


References
1.
Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View

2.
Liu T, Ma X, Liu W, Ling S, Zhao L, Xu L . Late Gadolinium Enhancement Amount As an Independent Risk Factor for the Incidence of Adverse Cardiovascular Events in Patients with Stage C or D Heart Failure. Front Physiol. 2016; 7:484. PMC: 5083842. DOI: 10.3389/fphys.2016.00484. View

3.
Gulati A, Jabbour A, Ismail T, Guha K, Khwaja J, Raza S . Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013; 309(9):896-908. DOI: 10.1001/jama.2013.1363. View

4.
Felker G, Thompson R, Hare J, Hruban R, Clemetson D, Howard D . Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000; 342(15):1077-84. DOI: 10.1056/NEJM200004133421502. View

5.
Kuruvilla S, Adenaw N, Katwal A, Lipinski M, Kramer C, Salerno M . Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2013; 7(2):250-258. PMC: 4007583. DOI: 10.1161/CIRCIMAGING.113.001144. View